Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
The association between undernutrition and the risk of colonization and disease with Vibrio cholerae O1, concentrations of salivary IgA and the serologic response to infection and to orally administered cholera B subunit were examined prospectively in a family study in Bangladesh. Children ages 1 to 8 years who were family contacts of patients hospitalized with culture-confirmed cholera were visited within 24 hours of the hospitalization and daily for 10 days, queried for the presence of diarrhea and cultured for V. cholerae O1. On Day 1 each child was weighed and saliva was collected to measure total IgA. On Days 1 and 21 blood was taken to assess vibriocidal and antitoxin titers, and on Days 1 and 2 B subunit or placebo was given orally as part of a trial to look for a toxin-blocking effect. Of 412 children enrolled in the study 35% (143) became infected with V. cholerae O1 and 49% (70) of these developed diarrhea. Undernutrition, defined in a child as weight less than 70% of the Harvard reference weight-for-age, was not associated with colonization, disease or the duration or severity of cholera. Moreover well-nourished children did not differ from undernourished children in their concentrations of salivary total IgA, initial serum antitoxin or vibriocidal antibodies or in their serologic response to colonization, disease or B subunit. The immune system in its response to cholera appears to be quite resistant to nutritional insults. The good antitoxin response to B subunit among undernourished children is of particular importance in considering the use of future oral cholera vaccines in areas where such undernutrition is common.
Glass
R I
RI
International Center for Diarrheal Disease Research, Dhaka, Bangladesh.
Svennerholm
A M
AM
Stoll
B J
BJ
Khan
M R
MR
Huda
S
S
Huq
M I
MI
Holmgren
J
J
D000284:Administration, Oral; D001835:Body Weight; D002648:Child; D015362:Child Nutrition Disorders / Q000150:complications*; D002675:Child, Preschool; D002771:Cholera / Q000150:complications* / Q000517:prevention & control; D022121:Cholera Vaccines; D003967:Diarrhea / Q000150:complications; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000032:analysis*; D007223:Infant; D011446:Prospective Studies; D012463:Saliva; D013997:Time Factors; D014611:Vaccination
D022121:Cholera Vaccines; D007071:Immunoglobulin A, Secretory